References

Cancer Statistics, 2013

2013 · External reference

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

10.1002/ijc.25516 · 2010 · External reference

Estimation and projection of the national profile of cancer mortality in China: 1991–2005

10.1038/sj.bjc.6601813 · 2004 · External reference

Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis

10.1001/jama.2010.534 · 2010 · External reference

Surgical treatment of advanced gastric cancer: Japanese perspective

10.1159/000101896 · 2007 · External reference

The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the “different disease” hypothesis.

10.1002/(sici)1097-0142(20000215)88:4<921::aid-cncr24>3.0.co;2-s · 2000 · External reference

Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer

10.1002/bjs.6408 · 2009 · External reference

Post-surgical chemotherapy versus surgery alone for resectable gastric cancer

2013 · External reference

Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer

10.1200/jco.2011.36.5908 · 2011 · External reference

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

10.1016/s0140-6736(11)61873-4 · 2012 · External reference

Adjuvant capecitabine and oxaliplatin (XELOX) for gastric cancer after D2 gastrectomy: Final results of the CLASSIC trial (abstract)

2013 · External reference

Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial

10.1200/jco.2011.39.1953 · 2012 · External reference

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

10.1056/nejmoa055531 · 2006 · External reference

Preclinical evaluation of docetaxel (Taxotere)

1995 · External reference

A phase II study of weekly docetaxel as salvage chemotherapy for advanced gastric cancer

10.1023/a:1008373814453 · 2000 · External reference

Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-flurouracil, folinci acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer

10.1097/00001813-200206000-00008 · 2002 · External reference

Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group

10.1200/jco.2006.10.4968 · 2007 · External reference

Unresolved reference

2010 · External reference

Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients

10.1016/s0140-6736(95)90637-1 · 1995 · External reference

Postoperative morbidity and mortality after Dl and D2 resections for gastric cancer:preliminary results of the MRC randomised controlled surgical trial

10.1016/s0140-6736(96)90144-0 · 1996 · External reference

Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomised surgical trial. Surgical Co-operative Group

10.1038/sj.bjc.6690243 · 1999 · External reference

One thousand consecutive gastrectomies without operative mortality

2002 · External reference

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesephageal junction.

10.1056/nejmoa010187 · 2001 · External reference

Who benefits from adjuvant radiation therapy for gastric cancer? A meta-analysis.

10.1016/j.ijrobp.2013.02.008 · 2013 · External reference

Chemoradiation therapy versus chemotherapy alone for gastric cancer after R0 surgical resection: a meta-analysis of randomized trials

10.1159/000354641 · 2014 · External reference